•  
  •  
  •  
  •  

2026-02-09 00:44:05

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • KSH International Q3 & 9M FY26: Record Revenue +59% YoY to ₹818 Cr, EBITDA +23%; Capacity Hits 43K MT
  • Advance Agrolife Q3 & 9M FY26: Revenue +25% YoY to ₹516 Cr, PAT +15% to ₹28 Cr Amid Expansion
  • Vidya Wires' WOS ALCU Industries Starts Commercial Production of Winding/Conductivity Products in Gujarat
  • Oswal Pumps 9M FY26: Revenue +47% YoY to ₹1,569 Cr, PAT +31% at 18% Margin on PM-KUSUM Surge
  • Sportking India Q3 & 9M FY26: PAT +33% YoY to ₹25 Cr, EBITDA +11% at 10% Margin; Greenfield Groundbreaking

Keywords Selected:  InjectableFacility

Stock Report

  • Lupin receives EIR from US FDA for its Nagpur Injectable Facility
  • Zydus receives EIR for the injectable facility located at Jarod
  • Closure of USFDA inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Zydus receives EIR for the oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Lupin receives 6 observations from USFDA for Nagpur Injectable facility
  • Eris Lifesciences receives ANVISA approval for Sterile Injectable Facility
  • Lupin receives EIR from US FDA for its Injectable Facility in Nagpur
  • Eugia Steriles Pvt Ltd receives EIR from USFDA for new injectable facility
  • Eugia Steriles Pvt Ltd receives 1st production approval from USFDA from new injectable facility
  • Lupin announces closure of US FDA Inspection at its Injectable Facility with Zero 483 Observations
  • Eugia Steriles Pvt Ltd gets 3 observations from USFDA for Injectable Facility
  • Windlas Biotech Limited commissions its State-of-the-Art Injectable facility
  • Eugia US Manufacturing LLC gets 10 observations from USFDA for East Windsor facility
  • Lupin Receives EIR from US FDA for its Injectable Facility in Nagpur
  • Alembic Pharmaceuticals Ltd receives EIR from USFDA for Injectable Facility at Karkhadi
  • Lupin receives approval from US FDA for Glycopyrrolate Injection, USP
  • USFDA inspection at Alembic Pharmaceuticals Injectable Facility (F-3) at Karkhadi
  • Zydus Lifesciences Ltd gets 3 observations from USFDA for Injectable Facility

Latest Post

  • KSH International Q3 & 9M FY26: Record Revenue +59% YoY to ₹818 Cr, EBITDA +23%; Capacity Hits 43K MT
  • Advance Agrolife Q3 & 9M FY26: Revenue +25% YoY to ₹516 Cr, PAT +15% to ₹28 Cr Amid Expansion
  • Vidya Wires' WOS ALCU Industries Starts Commercial Production of Winding/Conductivity Products in Gujarat
  • Oswal Pumps 9M FY26: Revenue +47% YoY to ₹1,569 Cr, PAT +31% at 18% Margin on PM-KUSUM Surge
  • Sportking India Q3 & 9M FY26: PAT +33% YoY to ₹25 Cr, EBITDA +11% at 10% Margin; Greenfield Groundbreaking


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025